PolarityBio, Inc.
PrivateLast Round
Early Funding
May 20, 2024
Total Funding Raised
$22.5M
Company Overview
PolarityBio, Inc. is a biotechnology company that develops regenerative multicellular biologics for chronic wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PolarityBio, Inc. Comparables
Compare PolarityBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lynch Regenerative Medicine | 80% | |
| RedDress | 80% | |
| CUTISS AG | 78% | |
PolarityBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 20, 2024 | ||||
| Debt | May 20, 2024 | ||||
| M&A | Aug 22, 2023 | ||||
| Private Placement | Mar 16, 2022 | ||||
| Private Placement | Jan 14, 2021 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 25, 2025
Grew 191% QoQ, from 11 to 32 employees.
- Oct 14, 2025
Grew 38% QoQ, from 8 to 11 employees.
PolarityBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PolarityBio, Inc.'s valuation, stock price, and market status.